GoodRx Holdings Inc GDRX

NAS: GDRX | ISIN: US38246G1085   14/11/2024
4,560 USD (-2,15%)
(-2,15%)   14/11/2024

18 juli 2024 · Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® · Persbericht

21 juni 2024 · Lost Money on GoodRx Holdings, Inc.(GDRX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky · Persbericht

18 juni 2024 · Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for Investors - Contact Levi & Korsinsky · Persbericht

17 juni 2024 · Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX) · Persbericht

14 juni 2024 · Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your Rights - GDRX · Persbericht

13 juni 2024 · SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx · Persbericht

11 juni 2024 · GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit · Persbericht

10 juni 2024 · Deadline in 11 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX) · Persbericht

6 juni 2024 · SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx · Persbericht

6 juni 2024 · Levi & Korsinsky Reminds GoodRx Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRX · Persbericht

5 juni 2024 · GoodRx Holdings, Inc. NASDAQ: GDRX: Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

4 juni 2024 · Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 21, 2024 in GoodRx Lawsuit - GDRX · Persbericht

31 mei 2024 · DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx · Persbericht

30 mei 2024 · Levi & Korsinsky Reminds GoodRx Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRX · Persbericht

28 mei 2024 · GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit · Persbericht

23 mei 2024 · Contact Levi & Korsinsky by June 21, 2024 Deadline to Join Class Action Against GoodRx Holdings, Inc. (GDRX) · Persbericht

16 mei 2024 · GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP · Persbericht

15 mei 2024 · GoodRx Holdings, Inc. Class Action: Levi & Korsinsky Reminds GoodRx Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRX · Persbericht

14 mei 2024 · GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit · Persbericht

13 mei 2024 · Levi & Korsinsky Notifies Shareholders of GoodRx Holdings, Inc.(GDRX) of a Class Action Lawsuit and an Upcoming Deadline · Persbericht

Mijn selecties